Approval · Notice of Compliance 10608 · 2009
UFLO: Notice of Compliance 10608
Issued September 24, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10608
- Date
- September 24, 2009
- Company
- Triton Pharma Inc.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Selective antagonist of alpha1A adrenoreceptor subtype in the prostate
- Canadian reference product
- FLOMAX (Boehringer Ingelheim (Canada) Ltd.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UFLO | 02333333 | Cancelled Pre Market |
Medicinal ingredients
- TAMSULOSIN HYDROCHLORIDE 0.4 MG per CAP